Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5′-diphosphocholine (citicoline): A study of 8 years of follow-up

Research output: Contribution to journalArticlepeer-review

Abstract

In this study we assessed, by simultaneous recordings of visual evoked potentials (VEPs) and pattern-electroretinograms (PERGs), the effects cytidine-5′-diphosphocholine (citicoline) on retinal function and/ or visual cortical responses in glaucoma patients. Thirty glaucoma patients were randomly divided into two age-matched groups: patients in group GC (15 patients) were treated with citicoline (1000 mg/die intramuscularly) for 2 months; patients in group GP (15 patients) were treated with placebo for 2 months. After 4 months of wash-out (month 6), GC patients underwent a further 2-month period of citicoline treatment (months 7-8) followed by another 4-month period of wash-out (months 9-12). In GP patients the wash-out was extended for a further 6 months (months 7-12). During the following 13-96 months, GC patients received additional 2-month periods of treatment with citicoline (each period followed by 4 months of wash-out) for a total of 16 periods in 8 years. GP patients were also examined at months 24, 26, 48, 60, 72, 84 and 96. In GC patients the first two treatments with citicoline induced a significant (p

Original languageEnglish
Pages (from-to)91-102
Number of pages12
JournalDocumenta Ophthalmologica
Volume110
Issue number1
DOIs
Publication statusPublished - Jan 2005

Keywords

  • Citicoline
  • Glaucoma
  • Innermost retinal layers
  • Pattern electroretinogram
  • Visual evoked potentials
  • Visual function
  • Visual pathways

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5′-diphosphocholine (citicoline): A study of 8 years of follow-up'. Together they form a unique fingerprint.

Cite this